IVRO OTC
InVitro International
1W: +0.0%
1M: -14.3%
3M: -29.7%
YTD: -39.9%
1Y: +0.0%
3Y: -17.2%
5Y: -60.0%
$0.06
-0.01 (-7.69%)
Weekly Expected Move ±10.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$7K
-107.4% ▼
Capital Expenditures
$1K
+0.0% ▲
Free Cash Flow
-$9K
-108.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$39K
+0.0% ▲
Net Change in Cash
$248K
+310.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $96K | $21K | $2K | $107K | $122K |
| Depreciation & Amort. | $3K | $4K | $3K | $5K | $6K |
| Stock-Based Comp. | $10K | $5K | $12K | $0 | $0 |
| Change in Working Capital | $45K | $21K | -$79K | -$20K | -$139K |
| Other Non-Cash Items | -$121K | -$59K | $4K | $6K | $4K |
| Operating Cash Flow | $32K | $41K | -$59K | $99K | -$7K |
| — Investing Activities — | |||||
| Capital Expenditures | -$3K | -$9K | -$850 | $0 | -$1K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$482K | -$99K | $0 | -$38K | -$35K |
| Investment Sales | $497K | $793K | $0 | $0 | $331K |
| Other Investing | $0 | $0 | -$816K | $0 | $0 |
| Investing Cash Flow | $12K | $685K | -$816K | -$38K | $294K |
| — Financing Activities — | |||||
| Net Debt Issuance | $101K | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | -$15K | $0 | $0 | -$39K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $101K | -$15K | $0 | $0 | -$39K |
| Net Change in Cash | $143K | $711K | -$875K | $60K | $248K |
| Cash End of Period | $522K | $1M | $357K | $417K | $665K |
| Free Cash Flow | $29K | $31K | -$60K | $99K | -$9K |